APO Research
Talk to an analyst

APO RESEARCH · REPORT

Opioid Narcotics

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Opioid Narcotics Market Outlook and Growth Opportunities 2026

27 December 2025190 pages

Choose your research edition.

Industry ResearchOpioid Narcotics Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Opioid Narcotics Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Opioid Narcotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Opioid Narcotics Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Opioid Narcotics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Opioid Narcotics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Opioid Narcotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Opioid Narcotics market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Opioid Narcotics market include Yichang Renfu Pharmaceutical Co., Ltd., Jiangsu Enhua Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Sinopharm Group Industrial Co., Ltd. Langfang Branch, Changzhou Siyao Pharmaceutical Co., Ltd., Reig Jofre, Pfizer, GSK and Fresenius Kabi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Opioid Narcotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Opioid Narcotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Opioid Narcotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Opioid Narcotics market size, projected growth trends, production technologies, key applications, and end-use industries.

Opioid Narcotics Segment by Company

Yichang Renfu Pharmaceutical Co., Ltd.

Jiangsu Enhua Pharmaceutical Co., Ltd.

Henan Lingrui Pharmaceutical Co., Ltd.

Sinopharm Group Industrial Co., Ltd. Langfang Branch

Changzhou Siyao Pharmaceutical Co., Ltd.

Reig Jofre

Pfizer

GSK

Fresenius Kabi

Daiichi Sankyo

AcelRx Pharmaceuticals, Inc

Abbott

Opioid Narcotics Segment by Type

Fentanyl

Remifentanil

Sufentanil

Opioid Narcotics Segment by Application

Hospital

Clinic

Other

Opioid Narcotics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Opioid Narcotics status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Opioid Narcotics market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Opioid Narcotics significant trends, drivers, influence factors in global and regions.

6. To analyze Opioid Narcotics competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Opioid Narcotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Opioid Narcotics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Opioid Narcotics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Opioid Narcotics market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Opioid Narcotics industry.

Chapter 3: Detailed analysis of Opioid Narcotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Opioid Narcotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Opioid Narcotics in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Opioid Narcotics Industry Trends Table 2. Opioid Narcotics Industry Drivers Table 3. Opioid Narcotics Industry Opportunities and Challenges Table 4. Opioid Narcotics Industry Restraints Table 5. Global Opioid Narcotics Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Opioid Narcotics Revenue Share by Company (2021-2026) Table 7. Global Opioid Narcotics Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Opioid Narcotics Sales Volume Share by Company (2021-2026) Table 9. Global Opioid Narcotics Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Opioid Narcotics Company Ranking, (2024-2026) & (USD Million) Table 11. Global Opioid Narcotics Key Company Manufacturing Base & Headquarters Table 12. Global Opioid Narcotics Company, Product Type & Application Table 13. Global Opioid Narcotics Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Opioid Narcotics by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Fentanyl Table 18. Significant Companies of Remifentanil Table 19. Significant Companies of Sufentanil Table 20. Global Opioid Narcotics Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Opioid Narcotics Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Opioid Narcotics Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Opioid Narcotics Sales Volume Share by Type (2021-2026) Table 24. Global Opioid Narcotics Sales Volume Share by Type (2027-2032) Table 25. Global Opioid Narcotics Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Opioid Narcotics Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Opioid Narcotics Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Opioid Narcotics Sales Value Share by Type (2021-2026) Table 29. Global Opioid Narcotics Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Other Table 33. Global Opioid Narcotics Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Opioid Narcotics Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Opioid Narcotics Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Opioid Narcotics Sales Volume Share by Application (2021-2026) Table 37. Global Opioid Narcotics Sales Volume Share by Application (2027-2032) Table 38. Global Opioid Narcotics Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Opioid Narcotics Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Opioid Narcotics Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Opioid Narcotics Sales Value Share by Application (2021-2026) Table 42. Global Opioid Narcotics Sales Value Share by Application (2027-2032) Table 43. Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Opioid Narcotics Sales by Region (2021-2026) & (K Units) Table 45. Global Opioid Narcotics Sales Market Share by Region (2021-2026) Table 46. Global Opioid Narcotics Sales by Region (2027-2032) & (K Units) Table 47. Global Opioid Narcotics Sales Market Share by Region (2027-2032) Table 48. Global Opioid Narcotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Opioid Narcotics Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Opioid Narcotics Sales Value Share by Region (2021-2026) Table 51. Global Opioid Narcotics Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Opioid Narcotics Sales Value Share by Region (2027-2032) Table 53. Global Opioid Narcotics Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Opioid Narcotics Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Opioid Narcotics Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Opioid Narcotics Sales by Country (2021-2026) & (K Units) Table 58. Global Opioid Narcotics Sales Market Share by Country (2021-2026) Table 59. Global Opioid Narcotics Sales by Country (2027-2032) & (K Units) Table 60. Global Opioid Narcotics Sales Market Share by Country (2027-2032) Table 61. Global Opioid Narcotics Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Opioid Narcotics Sales Value Market Share by Country (2021-2026) Table 63. Global Opioid Narcotics Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Opioid Narcotics Sales Value Market Share by Country (2027-2032) Table 65. Yichang Renfu Pharmaceutical Co., Ltd. Company Information Table 66. Yichang Renfu Pharmaceutical Co., Ltd. Business Overview Table 67. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 69. Yichang Renfu Pharmaceutical Co., Ltd. Recent Development Table 70. Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information Table 71. Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview Table 72. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 74. Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Development Table 75. Henan Lingrui Pharmaceutical Co., Ltd. Company Information Table 76. Henan Lingrui Pharmaceutical Co., Ltd. Business Overview Table 77. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 79. Henan Lingrui Pharmaceutical Co., Ltd. Recent Development Table 80. Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information Table 81. Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview Table 82. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio Table 84. Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Development Table 85. Changzhou Siyao Pharmaceutical Co., Ltd. Company Information Table 86. Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview Table 87. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio Table 89. Changzhou Siyao Pharmaceutical Co., Ltd. Recent Development Table 90. Reig Jofre Company Information Table 91. Reig Jofre Business Overview Table 92. Reig Jofre Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Reig Jofre Opioid Narcotics Product Portfolio Table 94. Reig Jofre Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Pfizer Opioid Narcotics Product Portfolio Table 99. Pfizer Recent Development Table 100. GSK Company Information Table 101. GSK Business Overview Table 102. GSK Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. GSK Opioid Narcotics Product Portfolio Table 104. GSK Recent Development Table 105. Fresenius Kabi Company Information Table 106. Fresenius Kabi Business Overview Table 107. Fresenius Kabi Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Fresenius Kabi Opioid Narcotics Product Portfolio Table 109. Fresenius Kabi Recent Development Table 110. Daiichi Sankyo Company Information Table 111. Daiichi Sankyo Business Overview Table 112. Daiichi Sankyo Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Daiichi Sankyo Opioid Narcotics Product Portfolio Table 114. Daiichi Sankyo Recent Development Table 115. AcelRx Pharmaceuticals, Inc Company Information Table 116. AcelRx Pharmaceuticals, Inc Business Overview Table 117. AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio Table 119. AcelRx Pharmaceuticals, Inc Recent Development Table 120. Abbott Company Information Table 121. Abbott Business Overview Table 122. Abbott Opioid Narcotics Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Abbott Opioid Narcotics Product Portfolio Table 124. Abbott Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Opioid Narcotics Distributors List Table 128. Opioid Narcotics Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Opioid Narcotics Product Image Figure 2. Global Opioid Narcotics Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Opioid Narcotics Sales Value (2021-2032) & (US$ Million) Figure 4. Global Opioid Narcotics Sales (2021-2032) & (K Units) Figure 5. Global Opioid Narcotics Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Opioid Narcotics Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Fentanyl Image Figure 10. Remifentanil Image Figure 11. Sufentanil Image Figure 12. Global Opioid Narcotics Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Opioid Narcotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Opioid Narcotics Sales Volume Share by Type (2021-2032) Figure 15. Global Opioid Narcotics Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Opioid Narcotics Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Opioid Narcotics Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Other Image Figure 21. Global Opioid Narcotics Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Opioid Narcotics Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Opioid Narcotics Sales Volume Share by Application (2021-2032) Figure 24. Global Opioid Narcotics Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Opioid Narcotics Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Opioid Narcotics Sales Value Share by Application (2021-2032) Figure 27. Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Opioid Narcotics Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Opioid Narcotics Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Opioid Narcotics Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Opioid Narcotics Sales Value (2021-2032) & (US$ Million) Figure 32. North America Opioid Narcotics Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Opioid Narcotics Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Opioid Narcotics Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Opioid Narcotics Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Opioid Narcotics Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Opioid Narcotics Sales Value (2021-2032) & (US$ Million) Figure 38. South America Opioid Narcotics Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Opioid Narcotics Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Opioid Narcotics Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Opioid Narcotics Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Opioid Narcotics Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Opioid Narcotics Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Opioid Narcotics Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Opioid Narcotics Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Fentanyl
  • Remifentanil
  • Sufentanil
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yichang Renfu Pharmaceutical Co., Ltd.
  • Jiangsu Enhua Pharmaceutical Co., Ltd.
  • Henan Lingrui Pharmaceutical Co., Ltd.
  • Sinopharm Group Industrial Co., Ltd. Langfang Branch
  • Changzhou Siyao Pharmaceutical Co., Ltd.
  • Reig Jofre
  • Pfizer
  • GSK
  • Fresenius Kabi
  • Daiichi Sankyo
  • AcelRx Pharmaceuticals, Inc
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Opioid Narcotics Sales Value (2021-2032)
  4. 1.2.2 Global Opioid Narcotics Sales Volume (2021-2032)
  5. 1.2.3 Global Opioid Narcotics Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Opioid Narcotics Market Dynamics
  1. 2.1 Opioid Narcotics Industry Trends
  2. 2.2 Opioid Narcotics Industry Drivers
  3. 2.3 Opioid Narcotics Industry Opportunities and Challenges
  4. 2.4 Opioid Narcotics Industry Restraints
3 Opioid Narcotics Market by Company
  1. 3.1 Global Opioid Narcotics Company Revenue Ranking in 2025
  2. 3.2 Global Opioid Narcotics Revenue by Company (2021-2026)
  3. 3.3 Global Opioid Narcotics Sales Volume by Company (2021-2026)
  4. 3.4 Global Opioid Narcotics Average Price by Company (2021-2026)
  5. 3.5 Global Opioid Narcotics Company Ranking (2024-2026)
  6. 3.6 Global Opioid Narcotics Company Manufacturing Base and Headquarters
  7. 3.7 Global Opioid Narcotics Company Product Type and Application
  8. 3.8 Global Opioid Narcotics Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Opioid Narcotics Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Opioid Narcotics Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Opioid Narcotics Market by Type
  1. 4.1 Opioid Narcotics Type Introduction
  2. 4.1.1 Fentanyl
  3. 4.1.2 Remifentanil
  4. 4.1.3 Sufentanil
  5. 4.2 Global Opioid Narcotics Sales Volume by Type
  6. 4.2.1 Global Opioid Narcotics Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Opioid Narcotics Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Opioid Narcotics Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Opioid Narcotics Sales Value by Type
  10. 4.3.1 Global Opioid Narcotics Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Opioid Narcotics Sales Value by Type (2021-2032)
  12. 4.3.3 Global Opioid Narcotics Sales Value Share by Type (2021-2032)
5 Opioid Narcotics Market by Application
  1. 5.1 Opioid Narcotics Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Opioid Narcotics Sales Volume by Application
  6. 5.2.1 Global Opioid Narcotics Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Opioid Narcotics Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Opioid Narcotics Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Opioid Narcotics Sales Value by Application
  10. 5.3.1 Global Opioid Narcotics Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Opioid Narcotics Sales Value by Application (2021-2032)
  12. 5.3.3 Global Opioid Narcotics Sales Value Share by Application (2021-2032)
6 Opioid Narcotics Regional Sales and Value Analysis
  1. 6.1 Global Opioid Narcotics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Opioid Narcotics Sales by Region (2021-2032)
  3. 6.2.1 Global Opioid Narcotics Sales by Region: 2021-2026
  4. 6.2.2 Global Opioid Narcotics Sales by Region (2027-2032)
  5. 6.3 Global Opioid Narcotics Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Opioid Narcotics Sales Value by Region (2021-2032)
  7. 6.4.1 Global Opioid Narcotics Sales Value by Region: 2021-2026
  8. 6.4.2 Global Opioid Narcotics Sales Value by Region (2027-2032)
  9. 6.5 Global Opioid Narcotics Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Opioid Narcotics Sales Value (2021-2032)
  12. 6.6.2 North America Opioid Narcotics Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Opioid Narcotics Sales Value (2021-2032)
  15. 6.7.2 Europe Opioid Narcotics Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Opioid Narcotics Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Opioid Narcotics Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Opioid Narcotics Sales Value (2021-2032)
  21. 6.9.2 South America Opioid Narcotics Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Opioid Narcotics Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Opioid Narcotics Sales Value Share by Country, 2025 VS 2032
7 Opioid Narcotics Country-level Sales and Value Analysis
  1. 7.1 Global Opioid Narcotics Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Opioid Narcotics Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Opioid Narcotics Sales by Country (2021-2032)
  4. 7.3.1 Global Opioid Narcotics Sales by Country (2021-2026)
  5. 7.3.2 Global Opioid Narcotics Sales by Country (2027-2032)
  6. 7.4 Global Opioid Narcotics Sales Value by Country (2021-2032)
  7. 7.4.1 Global Opioid Narcotics Sales Value by Country (2021-2026)
  8. 7.4.2 Global Opioid Narcotics Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Opioid Narcotics Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Opioid Narcotics Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Opioid Narcotics Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Opioid Narcotics Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Opioid Narcotics Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Opioid Narcotics Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Opioid Narcotics Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Opioid Narcotics Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Opioid Narcotics Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Opioid Narcotics Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Opioid Narcotics Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Opioid Narcotics Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Opioid Narcotics Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Opioid Narcotics Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Opioid Narcotics Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Opioid Narcotics Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Opioid Narcotics Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Opioid Narcotics Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Opioid Narcotics Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Opioid Narcotics Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Opioid Narcotics Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Opioid Narcotics Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Opioid Narcotics Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Opioid Narcotics Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Opioid Narcotics Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Opioid Narcotics Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Opioid Narcotics Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Opioid Narcotics Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Opioid Narcotics Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Opioid Narcotics Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yichang Renfu Pharmaceutical Co., Ltd.
  2. 8.1.1 Yichang Renfu Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Yichang Renfu Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yichang Renfu Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  6. 8.1.5 Yichang Renfu Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Jiangsu Enhua Pharmaceutical Co., Ltd.
  8. 8.2.1 Jiangsu Enhua Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Jiangsu Enhua Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Enhua Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  12. 8.2.5 Jiangsu Enhua Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Henan Lingrui Pharmaceutical Co., Ltd.
  14. 8.3.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Henan Lingrui Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Henan Lingrui Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  18. 8.3.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch
  20. 8.4.1 Sinopharm Group Industrial Co., Ltd. Langfang Branch Company Information
  21. 8.4.2 Sinopharm Group Industrial Co., Ltd. Langfang Branch Business Overview
  22. 8.4.3 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sinopharm Group Industrial Co., Ltd. Langfang Branch Opioid Narcotics Product Portfolio
  24. 8.4.5 Sinopharm Group Industrial Co., Ltd. Langfang Branch Recent Developments
  25. 8.5 Changzhou Siyao Pharmaceutical Co., Ltd.
  26. 8.5.1 Changzhou Siyao Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Changzhou Siyao Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Changzhou Siyao Pharmaceutical Co., Ltd. Opioid Narcotics Product Portfolio
  30. 8.5.5 Changzhou Siyao Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Reig Jofre
  32. 8.6.1 Reig Jofre Company Information
  33. 8.6.2 Reig Jofre Business Overview
  34. 8.6.3 Reig Jofre Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Reig Jofre Opioid Narcotics Product Portfolio
  36. 8.6.5 Reig Jofre Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Opioid Narcotics Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GSK Opioid Narcotics Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Fresenius Kabi
  50. 8.9.1 Fresenius Kabi Company Information
  51. 8.9.2 Fresenius Kabi Business Overview
  52. 8.9.3 Fresenius Kabi Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Fresenius Kabi Opioid Narcotics Product Portfolio
  54. 8.9.5 Fresenius Kabi Recent Developments
  55. 8.10 Daiichi Sankyo
  56. 8.10.1 Daiichi Sankyo Company Information
  57. 8.10.2 Daiichi Sankyo Business Overview
  58. 8.10.3 Daiichi Sankyo Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Daiichi Sankyo Opioid Narcotics Product Portfolio
  60. 8.10.5 Daiichi Sankyo Recent Developments
  61. 8.11 AcelRx Pharmaceuticals, Inc
  62. 8.11.1 AcelRx Pharmaceuticals, Inc Company Information
  63. 8.11.2 AcelRx Pharmaceuticals, Inc Business Overview
  64. 8.11.3 AcelRx Pharmaceuticals, Inc Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 AcelRx Pharmaceuticals, Inc Opioid Narcotics Product Portfolio
  66. 8.11.5 AcelRx Pharmaceuticals, Inc Recent Developments
  67. 8.12 Abbott
  68. 8.12.1 Abbott Company Information
  69. 8.12.2 Abbott Business Overview
  70. 8.12.3 Abbott Opioid Narcotics Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Opioid Narcotics Product Portfolio
  72. 8.12.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Opioid Narcotics Value Chain Analysis
  2. 9.1.1 Opioid Narcotics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Opioid Narcotics Sales Mode & Process
  6. 9.2 Opioid Narcotics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Opioid Narcotics Distributors
  9. 9.2.3 Opioid Narcotics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst